NCT Number: NCT07283809
Major advances in cardiovascular medicine have been driven by innovations in basic research in biological and technical sciences. Despite the clear evidence regarding the treatments that have been demonstrated to be useful to improve patients' outcomes, their transferability to everyday clinical practice seems to be at least suboptimal. The European Society of Cardiology (ESC), therefore, planned to support a program, denominated EuroHeart, for continuous data collection of standardized and/or harmonized variables in common cardiovascular diseases, such as ACS, HF and A Fib. EuroHeart is an observational, prospective, multicentre initiative with continuous data collection in consecutive patients with ACS, HF and A Fib to support continuous quality of care improvement through the evaluation of quality indicators (QIs) defined by the ESC. All patients included in the EuroHeart initiative, will enter a 12 month longitudinal follow-up with the collection of clinical events and clinical status data.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Ospedale Valdarno S. Maria Della Gruccia - U.O. Malattie Cardiovascolari, Montevarchi, AREZZO, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
EuroHeart is an initiative of the European Society of Cardiology (ESC) supporting continuous quality-of-care improvement through individual patient data collection. The present registry component refers specifically to the Italian implementation of the EuroHeart programme, aimed at monitoring and improving adherence to ESC quality indicators within Italian clinical practice.
Time frame: From enrollment to 12 months follow-up
Proportion of patients with STEMI reperfused among those eligible (onset of symptoms to diagnosis <12 hours)
Time frame: From enrollment to 12 months follow-up
Proportion of patients with STEMI who receive timely reperfusion with PCI (wire crossing) within 90 minutes from initial diagnostic ECG
Time frame: From enrollment to 12 months follow-up
Rate of NSTEMI patients who receive invasive within 24 hours from their diagnosis
Time frame: From enrollment to 12 months follow-up
Use of radial access in case of invasive strategy for patients with STEMI and NSTEMI
Time frame: From enrollment to 12 months follow-up
The time between the initial STEMI diagnosis and arterial access (absolute value) for primary PCI
Time frame: From enrollment to 12 months follow-up
The proportion of patients with STEMI and NSTEMI who have an assessment of their left ventricular ejection fraction (LVEF) before hospital discharge
Time frame: From enrollment to 12 months follow-up
The proportion of patients with STEMI and NSTEMI who have their LDL cholesterol measured during hospitalization
Time frame: From enrollment to 12 months follow-up
Proportion of patients with STEMI and NSTEMI discharged on dual antiplatelet therapy
Time frame: From enrollment to 12 months follow-up
Proportion of patients discharged from hospital on Lipid Lowering Agents (LLA)
Time frame: From enrollment to 12 months follow-up
Proportion of patients with LVEF ≤40% who are discharged from hospital on angiotensin converting enzymes inhibitors (ACEi) or angiotensin receptor blockers (ARBs) or angiotensin receptor-neprilysin inhibitor (ARNI)
Time frame: From enrollment to 12 months follow-up
Proportion of patients with LVEF ≤40% who are discharged from hospital on beta blockers.
Time frame: 12 months follow-up
Proportion of patients with clinical events at 12 months
Contact information is provided by the study sponsor or research team.
Aldo P Maggioni, MD
CONTACT
055/5101361
Furio Colivicchi, MD
CONTACT
055/51013741
Heart Care Foundation
Other
European Unified Registries for Heart Care Evaluation and Randomised Trials
Acronym: EuroHeart ITA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03138473
ACS - Acute Coronary Syndrome, Acute Coronary Syndrome
Asyut, Egypt
View Trial DetailsNCT03103620
ACS - Acute Coronary Syndrome, Acute Coronary Syndrome
Aix, France
View Trial DetailsNCT06095557
ACS - Acute Coronary Syndrome, Acute Coronary Syndrome
New York, United States
View Trial DetailsNCT07064109
ACS - Acute Coronary Syndrome, Acute Coronary Syndrome
Shanghai, China
View Trial Details